In a new paper published in Clinical Nutrition, “Sarcopenic Diabetes Is an Under-Recognized and Unmet Clinical Priority,” nutrition and diabetes experts are calling attention to a little-known but serious complication of diabetes, the progressive loss of muscle mass and strength, a condition known as sarcopenic diabetes. Moreover, authors warn that the new class of weight loss drugs, like semaglutide, complicates this condition as weight loss with these drugs is caused, in part, by a decrease in muscle mass.
This article was originally published on MedicalXpress.com
